Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Other Operating Expenses (2024 - 2026)

Beta Bionics' Other Operating Expenses history spans 3 years, with the latest figure at $20.7 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 54.72% to $20.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $68.7 million, a 60.51% increase, with the full-year FY2025 number at $61.4 million, up 65.57% from a year prior.
  • Other Operating Expenses hit $20.7 million in Q1 2026 for Beta Bionics, up from $16.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for BBNX hit a ceiling of $20.7 million in Q1 2026 and a floor of $7.7 million in Q1 2024.
  • Historically, Other Operating Expenses has averaged $13.2 million across 3 years, with a median of $13.4 million in 2025.
  • The widest YoY moves for Other Operating Expenses: up 74.89% in 2025, down 51.18% in 2025.
  • Tracing BBNX's Other Operating Expenses over 3 years: stood at $10.8 million in 2024, then surged by 51.18% to $16.3 million in 2025, then increased by 26.94% to $20.7 million in 2026.
  • Business Quant data shows Other Operating Expenses for BBNX at $20.7 million in Q1 2026, $16.3 million in Q4 2025, and $16.0 million in Q3 2025.